# 2026-23205: CDC Explores Antibody Protection Against West Nile for High-Risk People

2026-23205, Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention: Request for Information, is a Federal Register notice from Health and Human Services Department, Centers for Disease Control and Prevention published 2026-11-16, effective Written comments must be received on or before January 15, 2027. (as of 2026-11-17).

- Canonical: https://policyrisk.com/federal-register/2026-23205
- As of: 2026-11-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-23205
- Title: Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention: Request for Information
- Type: Notice
- Agencies: Health and Human Services Department; Centers for Disease Control and Prevention
- Citation: 91 FR 73596
- Published: 2026-11-16
- Effective: Written comments must be received on or before January 15, 2027.
- Comments close: 2027-01-15
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-11-17

## In one line

CDC Explores Antibody Protection Against West Nile for High-Risk People

## Summary

The CDC wants your thoughts on a new plan to create special antibodies that help protect people from West Nile virus, especially those at high risk. They’re asking for ideas by January 15, 2027, to make sure the final product works well and keeps folks safe. This effort could lead to better prevention tools and possibly save lives, with no cost details yet but plenty of public input ahead!

## Abstract

The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. The objective of the target product profile is to describe key minimal and optimal attributes for a West Nile virus monoclonal antibody product that can be provided to patients at higher risk for severe West Nile virus disease as pre- or post- exposure prophylaxis. This input is a valuable component in developing a useful target product profile.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-23004](https://policyrisk.com/federal-register/2026-23004): Final Effect of the Designation of a Class of Employees for Addition to the Special Exposure Cohort, 2026-11-12
- [2026-22881](https://policyrisk.com/federal-register/2026-22881): Proposed Data Collection Submitted for Public Comment and Recommendations, 2026-11-10
- [2026-22819](https://policyrisk.com/federal-register/2026-22819): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-09
- [2026-22775](https://policyrisk.com/federal-register/2026-22775): Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 2026-11-09
- [2026-22330](https://policyrisk.com/federal-register/2026-22330): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-02
- [2026-22329](https://policyrisk.com/federal-register/2026-22329): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-02

## Sources
- [2026-23205 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/16/2026-23205/target-product-profile-for-monoclonal-antibodies-for-west-nile-virus-disease-prevention-request-for)
- [2026-23205 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-16/pdf/2026-23205.pdf)

## Related
- [Previous: 2026-23204, Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease:…](https://policyrisk.com/federal-register/2026-23204)
- [Next: 2026-23206, Target Product Profile for a Human West Nile Virus Vaccine: Request for Informa…](https://policyrisk.com/federal-register/2026-23206)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-23205 (as of 2026-11-17).
